A prospective study to compare immediate with deferred treatment in advanced, localised and asymptomatic metastatic newly diagnosed prostatic carcinoma
Not Applicable
Completed
- Conditions
- Prostate cancerCancer
- Registration Number
- ISRCTN14557194
- Lead Sponsor
- Medical Research Council (MRC) (UK)
- Brief Summary
1997 results in: https://www.ncbi.nlm.nih.gov/pubmed/9052476 (added 15/11/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 938
Inclusion Criteria
1. Histologically proven adenocarcinoma of the prostate
2. Stage T2-T4 M0 or T1-T4 M1 (provided metastases are asymptomatic)
3. World Health Organisation (WHO) performance status 0-2
4. Life expectancy of >1 year
5. No previous or coexisting non prostatic malignancy except basal cell carcinoma
6. No previous treatment for prostatic carcinoma other than transurethral resection (TUR)
7. Patients in whom a deferred policy is inappropriate should not be entered into this study
Exclusion Criteria
Not provided at time of registration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration.